Mitochondrial encephalopathy, lactic acidosis and stroke-like syndrome (MELAS): A case report, presentation, and management

Southern Medical Journal

Volumn 100, Issue 1, 2007, Pages 70-72

  Patel, Ilaben Bhagubhai ^a   Sidani, Mohamad ^a   Zoorob, Roger ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Encephalopathy; Lactic acidosis; Mitochondria; Nonvascular; Strokes

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DEATH; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HUMAN; LABORATORY TEST; LACTIC ACIDOSIS; MENTAL DEFICIENCY; MITOCHONDRIAL ENCEPHALOPATHY; OXIDATIVE PHOSPHORYLATION; PERCEPTION DEAFNESS; PHYSICAL DISABILITY; STROKE; SYMPTOM;

ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DNA, MITOCHONDRIAL; ELECTROENCEPHALOGRAPHY; FATAL OUTCOME; FEMALE; HUMANS; MELAS SYNDROME; MENTAL RETARDATION; MUSCLE, SKELETAL; MUTATION;

EID: 33846265321     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000223691.66759.8f     Document Type: Article

References (14)

1. Mandava P, Kent TA. Metabolic disease and stroke: MELAS. Emedicine 2005 August 25, pp 1-15. Available at:http://www.emedicine.com/NEURO/topic580.htm.
2. Fernando S. MELAS syndrome. Emedicine 2005 August 25, pp 1-20. Available at: http://www.emedicine.com/PED/topic1406.htm.
3. Textbook of Pediatrics. 16th ed. Philadelphia: WB Saunders, 2000:416, 1845-1848.
4. Borner GV, Zeviani M, Tiranti V, et al. Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum Mol Genet 2000;9:467-475.
5. Lam CW, Lau CH, Williams JC, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediatr 1997;156:562-564.
6. Oguro H, Iijima K, Takahashi K, et al. Successful treatment with succinate in a patient with MELAS. Intern Med 2004;43:427-431.
7. Singh B, Low PS, Yeo JF. MELAS: a case report. Ann Acad Med Singapore 2004;33 (Suppl):69S-71S.
8. Haslem RHA. Mitochondrial encephalomyopathies. In: Behrman RE, Kliegman R, Jenson HB, eds. Nelson.
9. Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): current concepts. J Child Neurol 1994;9:4-13.
10. Berbel-Garcia A, et al. Coenzyme Q 10 improves lactic acidosis, stroke-like episodes, and epilepsy in a patient with MELAS. Clin Neuropharmacol 2004;27:187-191.
11. Flierl A, Reichmann H, Seibel P. Pathophysiology of the MELAS 3243 transition mutation. J Biol Chem 1997;272:27189-27196.
12. Mahoney DJ, Parise G, Tarnopolsky MA. Nutritional and exercise based therapies in the treatment of mitochondrial disease. Curr Opin Clin Nutr Metab Care 2002;5:619-629.
13. Chou YJ, Ou CY, Hsu TY, et al. Prenatal diagnosis of a fetus harboring an intermediate load of the A3243G mutation in a maternal carrier diagnosed with MELAS syndrome. Prenat Diagn 2004;24:367-370.
14. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-488.